NCT07046221 2025-07-20Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or SurgeryFujian Cancer HospitalPhase 2 Not yet recruiting60 enrolled
NCT05648994 2022-12-13TCR-T Cells for the Treatment NY-ESO-1-positive Advanced Solid TumorsFujian Cancer HospitalPhase EARLY_PHASE1 Not yet recruiting30 enrolled